Targeted Myostatin Gene Editing in Multiple Mammalian Species Directed by a Single Pair of TALE Nucleases
Myostatin (MSTN) is a negative regulator of skeletal muscle mass. Strategies to block myostatin signaling pathway have been extensively pursued to increase muscle mass in various disease settings including muscular dystrophy. Here, we report a new class of reagents based on transcription activator-l...
Main Authors: | Li Xu, Piming Zhao, Andrew Mariano, Renzhi Han |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2013-01-01
|
Series: | Molecular Therapy: Nucleic Acids |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253116301706 |
Similar Items
-
Site-directed nucleases as tools for genome editing in fish
by: Radev, Zlatko
Published: (2014) -
Design and optimization of engineered nucleases for genome editing applications
by: Lin, Yanni
Published: (2016) -
Targeted Editing of Myostatin Gene in Sheep by Transcription Activator-like Effector Nucleases
by: Xinxia Zhao, et al.
Published: (2016-03-01) -
Homologous recombination-mediated targeted integration in monkey embryos using TALE nucleases
by: Chu Chu, et al.
Published: (2019-01-01) -
Genome editing of oncogenes with ZFNs and TALENs: caveats in nuclease design
by: Sumitra Shankar, et al.
Published: (2018-10-01)